BATF2 and breast cancer: The qRT-PCR assay showed that the positive rates of serum and exosomal BATF2 mRNA expressions were 45.00% (27/60) and 41.67% (25/60) in BC patients, respectively, versus the positive rates of 57.14% (32/56) and 51.80% (29/56) in healthy controls.